FindTrial
Sign In

Comparing 0.25% LEVOBUPIVACAINE and 0.25% ROPIVACAINE IN PENG BLOCK FOR PATIENT POSITIONING DURING SUBARACHNOID BLOCK IN HIP FRACTURE SURGERY

0.25% LEVOBUPIVACAINE VERSUS 0.25% ROPIVACAINE IN PENG BLOCK FOR PATIENT POSITIONING DURING SUBARACHNOID BLOCK IN HIP FRACTURE SURGERY: RANDOMISED COMPARATIVE STUDY.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099721
Enrollment
60
Registered
2025-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M638- Disorders of muscle in diseases classified elsewhere Health Condition 2: I788- Other diseases of capillaries

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Rohilkhand medical college bareilly Pradesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade 1-2

Exclusion criteria

Exclusion criteria: Allergic to LA Infection at the site of injection Coagulopathy and bleeding disorder

Design outcomes

Primary

MeasureTime frame
Effectiveness of drug in 12monthsTimepoint: Effectiveness of drug—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Mayur Masudi

Rohilkhand medical college bareilly Pradesh

Mayurm506@gmail.com9632638874

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026